Patents by Inventor Nirk E. QUISPE CALLA

Nirk E. QUISPE CALLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platforms and methods for optimizing host antigen presentation and host antitumor and antipathogen immunity
    Patent number: 11850279
    Abstract: Disclosed herein are methods and platforms for increasing utility and efficacy of a cellular vaccine. Specifically, disclosed are steps that optimize ex vivo B cell expansion and boost host in vivo immunity. Also disclosed is a platform for enhancing effectiveness of antigen presentation and antigen-specific immune responses. Also disclosed is a method for enhancing effectiveness of APCs in a subject. Also disclosed are vaccines and kits based on the platform.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: December 26, 2023
    Assignee: Ohio State Innovation Foundation
    Inventors: Thomas L Cherpes, Nirk E. Quispe Calla, Rodolfo Daniel Vicetti Miguel
  • METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY
    Publication number: 20210015914
    Abstract: Disclosed herein is a vaccine comprising an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp. Also disclosed are methods of treating or preventing diseases comprising administering to a subject a vaccine, wherein the vaccine comprises art antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: Thomas CHERPES, Nirk E. QUISPE CALLA, Rodolfo Daniel VICETTI MIGUEL
  • Methods and compositions related to accelerated humoral affinity
    Patent number: 10835601
    Abstract: Disclosed herein is a vaccine comprising an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp. Also disclosed are methods of treating or preventing diseases comprising administering to a subject a vaccine, wherein the vaccine comprises an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: November 17, 2020
    Assignee: Ohio State Innovation Foundation
    Inventors: Thomas Cherpes, Nirk E. Quispe Calla, Rodolfo Daniel Vicetti Miguel
  • PLATFORMS AND METHODS FOR OPTIMIZING HOST ANTIGEN PRESENTATION AND HOST ANTITUMOR AND ANTIPATHOGEN IMMUNITY
    Publication number: 20190224298
    Abstract: Disclosed herein are methods and platforms for increasing utility and efficacy of a cellular vaccine. Specifically, disclosed are steps that optimize ex vivo B cell expansion and boost host in vivo immunity. Also disclosed is a platform for enhancing effectiveness of antigen presentation and antigen-specific immune responses. Also disclosed is a method for enhancing effectiveness of APCs in a subject. Also disclosed are vaccines and kits based on the platform.
    Type: Application
    Filed: July 13, 2017
    Publication date: July 25, 2019
    Applicant: OHIO STATE INNOVATION FOUNDATION
    Inventors: Thomas L. CHERPES, Nirk E. QUISPE CALLA, Rodolfo Daniel VICETTI MIGUEL
  • METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY
    Publication number: 20180369366
    Abstract: Disclosed herein is a vaccine comprising an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp. Also disclosed are methods of treating or preventing diseases comprising administering to a subject a vaccine, wherein the vaccine comprises an antigen and a protein, peptide, or carbohydrate of Chlamydia spp., or a fragment thereof, wherein the antigen is not derived from a Chlamydia spp.
    Type: Application
    Filed: November 9, 2016
    Publication date: December 27, 2018
    Inventors: Thomas CHERPES, Nirk E. QUISPE CALLA, Rodolfo Miguel VICETTI